Wellington Management Group LLP Xenon Pharmaceuticals Inc. Call Options Transaction History
Wellington Management Group LLP
- $545 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XENE
# of Institutions
240Shares Held
74.5MCall Options Held
169KPut Options Held
279K-
Avoro Capital Advisors LLC New York, NY5.4MShares$220 Million2.96% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.17MShares$170 Million1.42% of portfolio
-
Janus Henderson Group PLC London, X03.94MShares$161 Million0.08% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$147 Million8.35% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$130 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.54B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...